1 / 4

Laboratory Monitoring of HIV Infection: Key Questions Addressed

Join us for Session WEPDB01 on July 25, 2012, focusing on critical laboratory monitoring questions for managing HIV infections in resource-limited settings. Engage with experts as they discuss testing frequencies, viral suppression, dried blood spots, and dual infection diagnostics.

priscilla-hunt
Download Presentation

Laboratory Monitoring of HIV Infection: Key Questions Addressed

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. LABORATORY MONITORING OF HIV INFECTION SESSION WEPDB01 13:00-14:00 HRS Wednesday, July 25, 2012 SESSION WEPDB01: Laboratory Monitoring of HIV Infection

  2. Participants • Chair • Robert W. Coombs, MD, PhD, FRCPC • University of Washington, Seattle, WA • POSTER PRESENTORS • WEPDB0101: Howard Gale, MD, MT (ASCP) • VA Medical Center, Washington, DC • WEPDB0102: Charlotte Charpentier, PharmD, PhD • Laboratoire de Virologie; HôpitalBichat-Claude Bernard; Paris, France • WEPDB0103: Kenneth Ouma, PhD • KEMRI-CDC, Kisumu, Kenya • WEPDB0104: Dana Raugi, MPH • University of Washington, Seattle, WA SESSION WEPDB01: Laboratory Monitoring of HIV Infection

  3. RULES • 5 minute presentation; 2 minutes for clarification • 30 minutes for questions & general discussion between the panelists and audience • We will focus on four questions of relevance to the resource-limited setting SESSION WEPDB01: Laboratory Monitoring of HIV Infection

  4. Questions • LABORATORY MONITORING OF HIV INFECTION: • What is the ideal testing frequency for HIV RNA and CD4 monitoring? • VIRAL SUPPRESSION: • What level of HIV-1 RNA defines “virological” failure? • DRIED BLOOD SPOTS: • Simple/rapid specimen collection and testing – what is required to validate DBS for HIV RNA/DNA? • DUAL HIV-1/-2 INFECTION: • Do we need better dual diagnostic tests for HIV-1/-2? SESSION WEPDB01: Laboratory Monitoring of HIV Infection

More Related